We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
+6.8%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$9.78B
AUM Growth
+$239M
Cap. Flow
-$199M
Cap. Flow %
-2.04%
Top 10 Hldgs %
39.84%
Holding
1,386
New
76
Increased
471
Reduced
763
Closed
70

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$24.4M
2
ORCL icon
Oracle
ORCL
+$10.8M
3
AMZN icon
Amazon
AMZN
+$10.3M
4
COST icon
Costco
COST
+$7.38M
5
XOM icon
ExxonMobil
XOM
+$6.78M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$32.3M
2
ACN icon
Accenture
ACN
+$18.1M
3
ABBV icon
AbbVie
ABBV
+$14.4M
4
TMO icon
Thermo Fisher Scientific
TMO
+$13.3M
5
CAT icon
Caterpillar
CAT
+$10.7M

Sector Composition

Rank Sector Weight
1 Technology 37.1%
2 Consumer Discretionary 11.12%
3 Healthcare 10.76%
4 Financials 10.45%
5 Communication Services 10.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AIT icon
676
Applied Industrial Technologies
AIT
$11.8B
$1.01M 0.01%
5,207
-329
-6% -$62.7K
FLR icon
677
Fluor
FLR
$7.12B
$1.01M 0.01%
23,097
+265
+1% +$11K
KBR icon
678
KBR
KBR
$4.79B
$1M 0.01%
15,607
-4,717
-23% -$305K
HQY icon
679
HealthEquity
HQY
$7.97B
$1M 0.01%
11,601
-709
-6% -$57.3K
ATR icon
680
AptarGroup
ATR
$8.46B
$999K 0.01%
7,098
-751
-10% -$109K
CVNA icon
681
Carvana
CVNA
$53.3B
$995K 0.01%
38,655
+6,885
+22% +$139K
TWLO icon
682
Twilio
TWLO
$36.5B
$991K 0.01%
17,440
+561
+3% +$33.1K
OHI icon
683
Omega Healthcare
OHI
$13.9B
$984K 0.01%
28,732
-4,589
-14% -$145K
ARMK icon
684
Aramark
ARMK
$15.3B
$980K 0.01%
28,798
-2,867
-9% -$93K
RRX icon
685
Regal Rexnord
RRX
$10.5B
$966K 0.01%
7,143
-748
-9% -$116K
BEN icon
686
Franklin Templeton
BEN
$17.6B
$959K 0.01%
42,904
-3,272
-7% -$78.8K
MKSI icon
687
MKS Inc
MKSI
$17.3B
$956K 0.01%
7,319
-337
-4% -$42.5K
GWRE icon
688
Guidewire Software
GWRE
$17.1B
$953K 0.01%
6,908
+3,066
+80% +$369K
SF
689
Stifel
SF
$12.3B
$934K 0.01%
16,643
-1,908
-10% -$101K
PCOR icon
690
Procore
PCOR
$9.68B
$933K 0.01%
14,067
+3,545
+34% +$246K
CMC icon
691
Commercial Metals
CMC
$7.48B
$932K 0.01%
16,957
-1,150
-6% -$63.4K
FHN icon
692
First Horizon
FHN
$11.7B
$930K 0.01%
58,986
-7,870
-12% -$119K
HALO icon
693
Halozyme
HALO
$12B
$930K 0.01%
17,762
-1,101
-6% -$48.3K
DCI icon
694
Donaldson
DCI
$10.7B
$927K 0.01%
12,960
-5,843
-31% -$429K
UFPI icon
695
UFP Industries
UFPI
$4.74B
$926K 0.01%
8,272
-510
-6% -$59.3K
EHC icon
696
Encompass Health
EHC
$11.9B
$923K 0.01%
10,759
-1,761
-14% -$148K
LPX icon
697
Louisiana-Pacific
LPX
$4.98B
$922K 0.01%
11,194
+3,561
+47% +$297K
CAVA icon
698
CAVA Group
CAVA
$7.82B
$913K 0.01%
9,846
+4,803
+95% +$371K
ITCI
699
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$913K 0.01%
13,329
+7,671
+136% +$532K
EXAS
700
DELISTED
Exact Sciences
EXAS
$912K 0.01%
21,576
+799
+4% +$44K

Similar funds

Xponance's Q2 2024 Portfolio in Review

As of Q2 2024, Xponance held 1,386 positions worth $9.78B, up 2.5% from $9.54B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Xponance's Q2 2024 filing shows 76 new, 471 increased, 763 reduced and 70 closed positions. Its largest new stake was GE Vernova: 36,466 shares worth $6.25M. The largest sale was UnitedHealth, an estimated $32.3M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 34% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Xponance's largest Q2 2024 buy was GE Vernova: 36,466 shares worth $6.25M.
  • Xponance added most to Merck in Q2 2024, an estimated $24.4M increase.
  • Xponance's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $32.3M.
  • Xponance fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $8.15M.
  • Xponance's ten largest holdings make up 40% of its $9.78B portfolio in Q2 2024.
  • Xponance opened 76 new positions and closed 70 in Q2 2024.
  • Xponance's portfolio value rose 2.5% quarter-over-quarter to $9.78B.

Based on Xponance's 13F filing for Q2 2024, filed 14 Aug 2024.